Solicitation of Nominations for Appointment to the Genomic Medicine Program Advisory Committee, 35741-35742 [2015-15219]
Download as PDF
<![CDATA[
tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 119 / Monday, June 22, 2015 / Notices
Under 12 CFR 1.3(h)(2), a national
bank may request an OCC determination
that it may invest in an entity that is
exempt from registration under section
3(c)(1) of the Investment Company Act
of 1940 1 if the portfolio of the entity
consists exclusively of assets that a
national bank may purchase and sell for
its own account. The OCC uses the
information contained in the request as
a basis for ensuring that a bank’s
investment is consistent with its
investment authority under applicable
law and does not pose unacceptable
risk.
Under 12 CFR 1.7(b), a national bank
may request OCC approval to extend the
five-year holding period for securities
held in satisfaction of debts previously
contracted (DPC) for up to an additional
five years. The bank must provide a
clearly convincing demonstration of
why any additional holding period is
needed. The OCC uses the information
in the request to ensure, on a case-bycase basis, that the bank’s purpose in
retaining the securities is not
speculative and that the bank’s reasons
for requesting the extension are
adequate. The OCC also uses the
information to evaluate the risks to the
bank of extending the holding period,
including potential effects on the bank’s
safety and soundness.
Type of Review: Extension of a
currently approved collection.
Affected Public: Businesses or other
for-profit.
Estimated Number of Respondents:
25.
Estimated Total Annual Burden: 460
hours.
Frequency of Response: On occasion.
The OCC published a 60-day Federal
Register notice concerning this
collection on April 14, 2015, (80 FR
20076). No comments were received.
Comments continue to be invited on:
(a) Whether the collection of
information is necessary for the proper
performance of the functions of the
OCC, including whether the information
has practical utility;
(b) The accuracy of the OCC’s
estimate of the burden of the collection
of information;
(c) Ways to enhance the quality,
utility, and clarity of the information to
be collected;
(d) Ways to minimize the burden of
the collection on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and
(e) Estimates of capital or start-up
costs and costs of operation,
1 15
U.S.C. 80a–3(c)(1).
VerDate Sep<11>2014
17:45 Jun 19, 2015
Jkt 235001
maintenance, and purchase of services
to provide information.
Dated: June 17, 2015.
Mary H. Gottlieb,
Regulatory Specialist, Legislative and
Regulatory Activities Division.
[FR Doc. 2015–15255 Filed 6–19–15; 8:45 am]
BILLING CODE 4810–33–P
DEPARTMENT OF VETERANS
AFFAIRS
Solicitation of Nominations for
Appointment to the Genomic Medicine
Program Advisory Committee
Department of Veterans Affairs.
Notice.
AGENCY:
ACTION:
The Department of Veterans
Affairs (VA), Veterans Health
Administration (VHA), is seeking
nominations of qualified candidates to
be considered for appointment as a
member of the Genomic Medicine
Program Advisory Committee
(hereinafter referred to as ‘‘the
Committee’’). The Committee was
established by the Secretary of the VA
pursuant to the provisions of the
Federal Advisory Committee Act, as
amended, 5 U.S.C. Appendix 2, to
advise the Secretary with respect to the
development of a world-class genomic
medicine program within the
Department, including policies to
collect and utilize both genetic and
other medical information to promote
optimal medical care and research that
contribute to the knowledge of diseases
prevalent in Veterans. The Committee
will be guided by the goal of using
genetic information to optimize clinical
care of Veterans, and enhance the study
and development of diagnostic tests and
treatments for diseases of particular
relevance to Veterans. Nominations of
qualified candidates in the area of
genomic medicine from healthcare,
academia, and/or other government
agencies are being sought to fill
vacancies on the Committee.
DATES: Nominations for membership on
the Committee must be received no later
than 5:00 p.m. EDT on July 15, 2015.
ADDRESSES: All nominations should be
mailed to Veterans Health
Administration, Department of Veterans
Affairs, 810 Vermont Ave. NW. (10P9B),
Attention: Sumitra Muralidhar;
Washington, DC 20420, or emailed to
Sumitra.muralidhar@va.gov.
FOR FURTHER INFORMATION CONTACT: Dr.
Sumitra Muralidhar, Designated Federal
Officer, Genomic Medicine Program
Advisory Committee, or by email at
Sumitra.muralidhar@va.gov. A copy of
SUMMARY:
PO 00000
Frm 00118
Fmt 4703
Sfmt 4703
35741
the Committee charter and list of the
current membership can be obtained by
contacting Dr. Muralidhar.
SUPPLEMENTARY INFORMATION: The
Genomic Medicine Program Advisory
Committee was established by the
Secretary of VA.
VHA is requesting nominations for
two vacancies on the Committee. The
Committee will be composed of
approximately 12 members. The
members of the Committee are
appointed by the Secretary and include,
but are not limited to:
• Members of the medical and
scientific communities representing
disciplines such as, but not limited to,
medical genetics, genomic technologies,
bioinformatics, computation, statistical
genetics, and genomic policy.
To the extent possible, the Secretary
seeks members who have diverse
professional and personal qualifications.
We ask that nominations include
information of this type so that VA can
ensure a balanced Committee
membership.
Individuals appointed to the
Committee by the Secretary shall be
invited to serve a two- or three-year
term. The Secretary may reappoint a
member for an additional term of
service. Committee members will
receive travel expenses and a per diem
allowance for any travel made in
connection with duties as members of
the Committee and within federal travel
guidelines.
Requirements for Nomination
Submission: Nominations should be
typed (one nomination per nominator).
Nomination package should include: (1)
A letter of nomination that clearly states
the name and affiliation of the nominee,
the basis for the nomination (i.e.,
specific attributes which qualify the
nominee for service in this capacity),
and a statement from the nominee
indicating the willingness to serve as a
member of the Committee; (2) the
nominee’s contact information,
including name, mailing address,
telephone numbers, and email address;
(3) the nominee’s curriculum vitae (if
applicable); (4) a summary of the
nominee’s experience and qualifications
relative to the membership
considerations described above; and (5)
a statement confirming that he/she is
not a federally-registered lobbyist.
VA makes every effort to ensure that
the membership of VA Federal advisory
committees is fairly balanced in terms of
points of view represented and the
committee’s function. Appointments to
this Committee shall be made without
discrimination based on a person’s race,
color, religion, sex, sexual orientation,
E:\FR\FM\22JNN1.SGM
22JNN1
35742
Federal Register / Vol. 80, No. 119 / Monday, June 22, 2015 / Notices
gender identity, national origin, age,
disability, or genetic information.
Nominations must state that the
nominee appears to have no conflict of
interest that would preclude
membership. An ethics review is
conducted for each selected nominee.
Dated: June 17, 2015.
Rebecca Schiller,
Advisory Committee Management Officer.
[FR Doc. 2015–15219 Filed 6–19–15; 8:45 am]
BILLING CODE 8320–01–P
DEPARTMENT OF VETERANS
AFFAIRS
MyVA Advisory Committee
tkelley on DSK3SPTVN1PROD with NOTICES
Amend: Notice of Meeting.
The Department of Veterans Affairs
(VA) gives notice under the Federal
Advisory Committee Act, 5 U.S.C. App.
2., that the MyVA Advisory Committee
(MVAC) will meet July 14 and 15, 2015
at the Department of Veterans Affairs,
Washington DC VA Medical Center, 50
Irving Street NW., Freedom Auditorium,
Washington, DC 20422.
The purpose of the Committee is to
advise the Secretary, through the
VerDate Sep<11>2014
17:45 Jun 19, 2015
Jkt 235001
Executive Director, My VA Task Force
Office regarding the My VA initiative
and VA’s ability to rebuild trust with
Veterans and other stakeholders,
improve service delivery with a focus
on Veteran outcomes, and set the course
for longer-term excellence and reform of
the VA.
On July 14 from 8:00 a.m. to 2:00
p.m., the Committee will convene a
closed session in order to protect patient
privacy as the Committee tours the
Washington DC VA Medical Center. 5
U.S.C. 552b(b)(6). In the afternoon from
2:00 p.m. to 5:15 p.m., the Committee
will reconvene in an open session to
discuss the progress on and the
integration of the work in the five key
MyVA work streams—Veteran
Experience (explaining the efforts
conducted to improve the Veteran’s
experience), Employees Experience,
Support Services Excellence (such as
information technology and human
resources), Performance Improvement
(projects undertaken to date and those
upcoming), and VA Strategic
Partnerships.
On July 15, from 8:15 a.m. to 2:00
p.m., the Committee will discuss and
PO 00000
Frm 00119
Fmt 4703
Sfmt 9990
recommend areas for improvement on
VA’s work to date, plans for the future,
and integration of the MyVA efforts.
This session is open to the public. No
time will be allocated at this meeting for
receiving oral presentations from the
public. However, the public may submit
written statements for the Committee’s
review to Debra Walker, Designated
Federal Officer, MyVA Program
Management Office, Department of
Veterans Affairs, 1800 G Street NW.,
Room 880–40, Washington, DC 20420,
or email at Debra.Walker3@va.gov. Any
member of the public wishing to attend
the meeting or seeking additional
information should contact Ms. Walker.
Because the meeting will be held in
a Government building, anyone
attending must be prepared to show a
valid government issued photo ID.
Please allow 15 minutes before the
meeting begins for this process.
Dated: June 17, 2015.
Jelessa Burney,
Federal Advisory Committee Management
Officer.
[FR Doc. 2015–15218 Filed 6–19–15; 8:45 am]
BILLING CODE P
E:\FR\FM\22JNN1.SGM
22JNN1
]]>Agencies
[Federal Register Volume 80, Number 119 (Monday, June 22, 2015)]
[Notices]
[Pages 35741-35742]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-15219]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Solicitation of Nominations for Appointment to the Genomic
Medicine Program Advisory Committee
AGENCY: Department of Veterans Affairs.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Veterans Affairs (VA), Veterans Health
Administration (VHA), is seeking nominations of qualified candidates to
be considered for appointment as a member of the Genomic Medicine
Program Advisory Committee (hereinafter referred to as ``the
Committee''). The Committee was established by the Secretary of the VA
pursuant to the provisions of the Federal Advisory Committee Act, as
amended, 5 U.S.C. Appendix 2, to advise the Secretary with respect to
the development of a world-class genomic medicine program within the
Department, including policies to collect and utilize both genetic and
other medical information to promote optimal medical care and research
that contribute to the knowledge of diseases prevalent in Veterans. The
Committee will be guided by the goal of using genetic information to
optimize clinical care of Veterans, and enhance the study and
development of diagnostic tests and treatments for diseases of
particular relevance to Veterans. Nominations of qualified candidates
in the area of genomic medicine from healthcare, academia, and/or other
government agencies are being sought to fill vacancies on the
Committee.
DATES: Nominations for membership on the Committee must be received no
later than 5:00 p.m. EDT on July 15, 2015.
ADDRESSES: All nominations should be mailed to Veterans Health
Administration, Department of Veterans Affairs, 810 Vermont Ave. NW.
(10P9B), Attention: Sumitra Muralidhar; Washington, DC 20420, or
emailed to Sumitra.muralidhar@va.gov.
FOR FURTHER INFORMATION CONTACT: Dr. Sumitra Muralidhar, Designated
Federal Officer, Genomic Medicine Program Advisory Committee, or by
email at Sumitra.muralidhar@va.gov. A copy of the Committee charter and
list of the current membership can be obtained by contacting Dr.
Muralidhar.
SUPPLEMENTARY INFORMATION: The Genomic Medicine Program Advisory
Committee was established by the Secretary of VA.
VHA is requesting nominations for two vacancies on the Committee.
The Committee will be composed of approximately 12 members. The members
of the Committee are appointed by the Secretary and include, but are
not limited to:
Members of the medical and scientific communities
representing disciplines such as, but not limited to, medical genetics,
genomic technologies, bioinformatics, computation, statistical
genetics, and genomic policy.
To the extent possible, the Secretary seeks members who have
diverse professional and personal qualifications. We ask that
nominations include information of this type so that VA can ensure a
balanced Committee membership.
Individuals appointed to the Committee by the Secretary shall be
invited to serve a two- or three-year term. The Secretary may reappoint
a member for an additional term of service. Committee members will
receive travel expenses and a per diem allowance for any travel made in
connection with duties as members of the Committee and within federal
travel guidelines.
Requirements for Nomination Submission: Nominations should be typed
(one nomination per nominator). Nomination package should include: (1)
A letter of nomination that clearly states the name and affiliation of
the nominee, the basis for the nomination (i.e., specific attributes
which qualify the nominee for service in this capacity), and a
statement from the nominee indicating the willingness to serve as a
member of the Committee; (2) the nominee's contact information,
including name, mailing address, telephone numbers, and email address;
(3) the nominee's curriculum vitae (if applicable); (4) a summary of
the nominee's experience and qualifications relative to the membership
considerations described above; and (5) a statement confirming that he/
she is not a federally-registered lobbyist.
VA makes every effort to ensure that the membership of VA Federal
advisory committees is fairly balanced in terms of points of view
represented and the committee's function. Appointments to this
Committee shall be made without discrimination based on a person's
race, color, religion, sex, sexual orientation,
[[Page 35742]]
gender identity, national origin, age, disability, or genetic
information. Nominations must state that the nominee appears to have no
conflict of interest that would preclude membership. An ethics review
is conducted for each selected nominee.
Dated: June 17, 2015.
Rebecca Schiller,
Advisory Committee Management Officer.
[FR Doc. 2015-15219 Filed 6-19-15; 8:45 am]
BILLING CODE 8320-01-P
